GRAF FINCKENSTEIN FRIEDRICH has filed 76 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 58750 shares of IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 58750 | $0.00 | 58,750.0000 | 357,345 | 9999.99% | 16.44% |
| March 5, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 31246 | $0.00 | 148,477.0000 | 357,345 | 26.65% | 8.74% |
| March 5, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 16520 | $4.58 | 131,957.0000 | 357,345 | 11.13% | 4.62% |
| March 5, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 31246 | $0.00 | 62,504.0000 | 357,345 | 33.33% | 8.74% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 7122 | $3.79 | 117,231.0000 | 357,345 | 5.73% | 1.99% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8790 | $0.00 | 35,159.0000 | 357,345 | 20.00% | 2.46% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 0.0000 | 357,345 | 100.00% | 1.09% |
| March 2, 2026 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 12697 | $0.00 | 124,353.0000 | 357,345 | 11.37% | 3.55% |
| Dec. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 3,907.0000 | 334,511 | 49.99% | 1.17% |
| Dec. 1, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 4464 | $2.23 | 109,734.0000 | 334,511 | 3.91% | 1.33% |
| Dec. 1, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 8789 | $0.00 | 114,198.0000 | 334,511 | 8.34% | 2.63% |
| Dec. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3906 | $0.00 | 113,640.0000 | 334,511 | 3.56% | 1.17% |
| Dec. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1984 | $2.14 | 111,656.0000 | 334,511 | 1.75% | 0.59% |
| Dec. 1, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8789 | $0.00 | 43,949.0000 | 334,511 | 16.67% | 2.63% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8790 | $0.00 | 52,738.0000 | 334,511 | 14.29% | 2.63% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 6448 | $2.19 | 105,409.0000 | 334,511 | 5.76% | 1.93% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 12697 | $0.00 | 111,857.0000 | 334,511 | 12.80% | 3.80% |
| Sept. 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 7,813.0000 | 334,511 | 33.34% | 1.17% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 6448 | $1.76 | 99,160.0000 | 322,868 | 6.11% | 2.00% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 12695 | $0.00 | 105,608.0000 | 322,868 | 13.66% | 3.93% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 8789 | $0.00 | 61,528.0000 | 322,868 | 12.50% | 2.72% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 11,720.0000 | 322,868 | 25.00% | 1.21% |
| March 5, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 93750 | $0.00 | 93,750.0000 | 289,877 | 9999.99% | 32.34% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 33470 | $4.04 | 92,913.0000 | 289,877 | 26.48% | 11.55% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 62497 | $0.00 | 126,383.0000 | 289,877 | 97.83% | 21.56% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 58590 | $0.00 | 70,317.0000 | 289,877 | 45.45% | 20.21% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 15,626.0000 | 289,877 | 20.00% | 1.35% |
| Jan. 14, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 65,464.0000 | 289,877 | 4.49% | 0.97% |
| Jan. 14, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1578 | $5.89 | 63,886.0000 | 289,877 | 2.41% | 0.54% |
| Jan. 14, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 0.0000 | 289,877 | 100.00% | 0.97% |
| Dec. 2, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3906 | $0.00 | 64,633.0000 | 303,269 | 6.43% | 1.29% |
| Dec. 2, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 19,533.0000 | 303,269 | 16.66% | 1.29% |
| Dec. 2, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1982 | $9.07 | 62,651.0000 | 303,269 | 3.07% | 0.65% |
| Oct. 14, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 2,813.0000 | 303,269 | 50.00% | 0.93% |
| Oct. 14, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1428 | $9.77 | 60,727.0000 | 303,269 | 2.30% | 0.47% |
| Oct. 14, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 62,155.0000 | 303,269 | 4.74% | 0.93% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3907 | $0.00 | 23,439.0000 | 284,817 | 14.29% | 1.37% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3907 | $0.00 | 49,778.0000 | 284,817 | 8.52% | 1.37% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1983 | $10.85 | 47,795.0000 | 284,817 | 3.98% | 0.70% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 23438 | $0.00 | 71,233.0000 | 284,817 | 49.04% | 8.23% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 11891 | $10.85 | 59,342.0000 | 284,817 | 16.69% | 4.18% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 23438 | $0.00 | 23,437.0000 | 284,817 | 50.00% | 8.23% |
| July 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 47,299.0000 | 284,817 | 6.32% | 0.99% |
| July 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1428 | $8.68 | 45,871.0000 | 284,817 | 3.02% | 0.50% |
| July 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 5,626.0000 | 284,817 | 33.33% | 0.99% |
| June 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1982 | $8.37 | 44,486.0000 | 266,220 | 4.27% | 0.74% |
| June 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 3906 | $0.00 | 46,468.0000 | 266,220 | 9.18% | 1.47% |
| June 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 3906 | $0.00 | 27,346.0000 | 266,220 | 12.50% | 1.47% |
| April 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1427 | $11.89 | 42,562.0000 | 266,220 | 3.24% | 0.54% |
| April 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2812 | $0.00 | 43,989.0000 | 266,220 | 6.83% | 1.06% |
| April 15, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2812 | $0.00 | 8,439.0000 | 266,220 | 24.99% | 1.06% |
| March 4, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 15623 | $0.00 | 31,252.0000 | 235,131 | 33.33% | 6.64% |
| March 4, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 15623 | $0.00 | 49,230.0000 | 235,131 | 46.49% | 6.64% |
| March 4, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 8053 | $16.96 | 41,177.0000 | 235,131 | 16.36% | 3.42% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 105470 | $0.00 | 105,470.0000 | 235,131 | 9999.99% | 44.86% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 235,131 | 9999.99% | 19.94% |
| Jan. 16, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 11,251.0000 | 235,131 | 20.00% | 1.20% |
| Jan. 16, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 35,184.0000 | 235,131 | 8.69% | 1.20% |
| Jan. 16, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1577 | $8.37 | 33,607.0000 | 235,131 | 4.48% | 0.67% |
| Oct. 16, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1395 | $3.57 | 32,371.0000 | 245,817 | 4.13% | 0.57% |
| Oct. 16, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 33,766.0000 | 245,817 | 9.09% | 1.14% |
| Oct. 16, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 14,064.0000 | 245,817 | 16.67% | 1.14% |
| July 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2813 | $0.00 | 16,877.0000 | 224,481 | 14.29% | 1.25% |
| July 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1395 | $7.76 | 30,953.0000 | 224,481 | 4.31% | 0.62% |
| July 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2813 | $0.00 | 32,348.0000 | 224,481 | 9.52% | 1.25% |
| April 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 2812 | $0.00 | 19,690.0000 | 213,694,000 | 12.50% | 0.00% |
| April 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 1395 | $5.64 | 29,535.0000 | 213,694,000 | 4.51% | 0.00% |
| April 14, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 2812 | $0.00 | 30,930.0000 | 213,694,000 | 10.00% | 0.00% |
| March 2, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 159,259 | 9999.99% | 29.43% |
| March 2, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | A | Stock Option (right to buy) | 93750 | $0.00 | 93,750.0000 | 159,259 | 9999.99% | 58.87% |
| Jan. 17, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 11248 | $0.00 | 22,502.0000 | 159,259 | 33.33% | 7.06% |
| Jan. 17, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 4678 | $6.43 | 28,118.0000 | 159,259 | 14.26% | 2.94% |
| Jan. 17, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 11248 | $0.00 | 32,796.0000 | 159,259 | 52.20% | 7.06% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | F | Common Stock | 11023 | $6.11 | 21,548.0000 | 159,259 | 33.84% | 6.92% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Common Stock | 19690 | $0.00 | 32,571.0000 | 159,259 | 152.86% | 12.36% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | M | Restricted Stock Units | 19690 | $0.00 | 0.0000 | 159,259 | 100.00% | 12.36% |